Datroway significantly improves overall and progression-free survival in metastatic triple-negative breast cancer patients ineligible for immunotherapy. TROPION-Breast02 trial results highlight ...
Hosted on MSN
Study uncovers how beta blockers could halt the progression of triple negative breast cancer
Monash University researchers have identified a molecular biomarker in triple negative breast cancer (TNBC) tumors which could inform when beta blockers can play a role in "switching off" tumor ...
When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in ...
Trodelvy reduced risk of disease progression or death versus chemotherapy in patients with previously untreated metastatic triple-negative breast cancer. Treatment with Trodelvy (Sacituzumab govitecan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback